It should come as no surprise that a large part of the success with incretin-based therapies— like Ozempic, Wegovy, Mounjaro, and Zepbound—stems from the effective integration of lifestyle modifications, particularly nutrition. This success occurs at both the individual and programmatic levels. But it’s not always for the reasons you might expect. By the time most people begin incretin-based therapy, especially for weight management, they’ve often already tried a range of diets: calorie counting, commercial weight loss programs like Jenny Craig or Weight Watchers, and more. This time, they’re looking for something different—something that addresses the deeper pathophysiology and root causes…